drugset / Trial / NCT00815633
A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the biologic medication alefacept (Amevive) is effective and safe in the treatment of Pityriasis Rubra Pilaris.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-06
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alefacept | Protein / enzyme biologic | 15 mg | Intramuscular |